Preview

Experimental and Clinical Gastroenterology

Advanced search

An application experience of a specialized product based on 100% medium-chain triglyceride oil in diet therapy of a child with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency

https://doi.org/10.31146/1682-8658-ecg-186-2-106-113

Abstract

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) is a hereditary disease referred to the group of disorders of mitochondrial β-oxidation of fatty acids with autosomal recessive inheritance. The main symptoms include hypoglycemia, hepatic steatosis, cardiomyopathy, cardiac arrhythmias, progressive muscle hypotension. We present a case of successful diagnosis and treatment of a long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) with the use of 100% medium chain triglycerides’ oil product. The importance of the possibly earliest verification of the diagnosis and initiation of diet therapy using medium-chain triglyceride oils is emphasized, which allows to reduce the disease manifestations and determines the need to include diseases of mitochondrial fatty acids β-oxidation into the neonatal screening program.

About the Authors

E. A. Roslavtseva
National Medical Research Center of Children’s Health
Russian Federation


T. V. Bushueva
National Medical Research Center of Children’s Health; Pirogov Russian National Research Medical University
Russian Federation


T. E. Borovik
National Medical Research Center of Children’s Health; I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation


E. A. Kulebina
National Medical Research Center of Children’s Health
Russian Federation


A. N. Surkov
National Medical Research Center of Children’s Health; I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation


A. S. Potapov
National Medical Research Center of Children’s Health; Research Centre for Medical Genetics
Russian Federation


K. V. Savostianov
National Medical Research Center of Children’s Health
Russian Federation


A. A. Pushkov
National Medical Research Center of Children’s Health
Russian Federation


References

1. Cassandra L. Kniffin. Long-chain 3-hydroxyacyl-coa dehydrogenase deficiency. Available at: https://www.omim.org/entry/609016

2. Rare diseases are rare, but rare disease patients are numerous. Available at: https://www.orpha.net/consor/cgi-bin/index.php

3. Natarajan S.K., Ibdah J. A. Role of 3-hydroxy fatty acid-induced hepatic lipotoxicity in acute fatty liver of pregnancy. Int. J. Mol. Sci. 2018; 19(1): 322. DOI: 10.3390/ijms19010322

4. Westbrook R.H., Dusheiko G., Williamson C. Pregnancy and liver disease. J. Hepatol. 2016; 64(4): 933-45. DOI: 10.1016/j.jhep.2015.11.030

5. Vishwanath V. A. Fatty Acid Beta-Oxidation Disorders: A Brief Review. Ann Neurosci. 2016 Mar;23(1):51-5. doi: 10.1159/000443556. Epub 2016 Mar 11. PMID: 27536022; PMCID: PMC4934411.

6. Novikov P. V., Nikolaeva E. A., Namazova-Baranova L.S. et al. Federal clinical recommendations for care for children with a child deficiency of acyl-coa fatty acid dehydrogenase with a very long carbon chain. Moscow. 2015. Available at: https://med-gen.ru/docs/recomend-dificit.pdf (In Russ.)@@ П.В. Новиков, Е. А. Николаева, Л. С. Намазова-Баранова, Т. Э. Боровик, Т. В. Бушуева, Н. Г. Звонкова, С.И Куцев, Е. Ю. Захарова. Федеральные клинические рекомендации по оказанию медицинской помощи детям с дефицитом ацилкоадегидрогеназы жирных кислот с очень длинной углеродной цепью. Министерство здравоохранения Российской Федерации, Союз педиатров России, Российское общество медицинских генетиков. Москва 2015. https://med-gen.ru/docs/recomend-dificit.pdf

7. Immonen T., Turanlahti M., Paganus A., Keskinen P., Tyni T., Lapatto R. Earlier diagnosis and strict diets improve the survival rate and clinical course of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Acta Paediatr. 2016; 105(5): 549-54. DOI: 10.1111/apa.13313

8. Fraser H., Geppert J., Johnson R., et al. Evaluation of earlier versus later dietary management in longchain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review. Orphanet J Rare Dis. 2019; 14(1): 258. DOI: 10.1186/s13023-019-1226-y

9. Lotz-Havla A.S., Röschinger W., Schiergens K., Singer K., Karall D., Konstantopoulou V., et al. Fatal pitfalls in newborn screening for mitochondrial trifunctional protein (MTP)/long-chain 3-Hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Orphanet J Rare Dis. 2018; 13(1): 122. DOI: 10.1186/s13023-018-0875-6

10. Olpin S.E., Clark S., Andresen B. S., et al. Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency. J Inherit Metab Dis. 2005;28(4):533-44. doi: 10.1007/s10545-005-0533-8. PMID: 15902556.

11. Bodian D, Klein E., Iyer R, et al. Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates. Genet Med. 2016, 221-230. Doi: 10.1038/gim.2015.111

12. MR 2.3.1.2432-08 Norms of physiological needs for energy and nutrients for various groups of the population of the Russian Federation. (In Russ.) Avalable at: https://www.rospotrebnadzor.ru/documents/details.php? ELEMENT_ID=4583.@@ МР 2.3.1.2432-08 Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации. https://www.rospotrebnadzor.ru/documents/details.php? ELEMENT_ID=4583.


Review

For citations:


Roslavtseva E.A., Bushueva T.V., Borovik T.E., Kulebina E.A., Surkov A.N., Potapov A.S., Savostianov K.V., Pushkov A.A. An application experience of a specialized product based on 100% medium-chain triglyceride oil in diet therapy of a child with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Experimental and Clinical Gastroenterology. 2021;(2):106-113. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-186-2-106-113

Views: 8633


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)